Literature DB >> 20435099

Age-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study.

A M Cortez1, S Charntikov, T Der-Ghazarian, L R Horn, C A Crawford, S A McDougall.   

Abstract

kappa-Opioid receptor stimulation attenuates psychostimulant-induced increases in extracellular dopamine in the caudate-putamen (CPu) and nucleus accumbens of adult rats, while reducing cocaine-induced locomotor activity and stereotyped behaviors. Because kappa-opioid receptor agonists (e.g., U50,488 or U69,593) often affect the behavior of preweanling rats in a paradoxical manner, the purpose of the present study was to determine whether kappa-opioid receptor stimulation differentially affects dopaminergic functioning in the CPu depending on age. In vivo microdialysis was used to determine whether U50,488 (5 mg/kg) attenuates cocaine-induced dopamine overflow in the dorsal CPu on postnatal day (PD) 17 and PD 85. In the microinjection experiment, cocaine-induced stereotyped behaviors were assessed in adult and preweanling rats after bilateral infusions of vehicle or U50,488 (1.6 or 6.4 microg per side) into the CPu. Results showed that U50,488 attenuated the cocaine-induced increases in CPu dopamine overflow on PD 85, while the same dose of U50,488 did not alter dopamine dialysate levels on PD 17. Cocaine also increased stereotyped behaviors (repetitive motor movements, behavioral intensity scores, and discrete behaviors) at both ages, but adult rats appeared to exhibit more intense stereotypic responses than the younger animals. Consistent with the microdialysis findings, bilateral infusions of U50,488 into the dorsal CPu decreased the cocaine-induced stereotypies of adult rats, while leaving the behaviors of preweanling rats unaffected. These results suggest that the neural mechanisms underlying kappa-opioid/dopamine interactions in the CPu are not fully mature during the preweanling period. This lack of functional maturity may explain why kappa-opioid receptor agonists frequently induce different behavioral effects in young and adult rats. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435099      PMCID: PMC2900406          DOI: 10.1016/j.neuroscience.2010.04.052

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  75 in total

1.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 2.  Opioid receptor-coupled second messenger systems.

Authors:  S R Childers
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

3.  Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.

Authors:  T J De Vries; F Hogenboom; A H Mulder; A N Schoffelmeer
Journal:  Brain Res Dev Brain Res       Date:  1990-06-01

4.  Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens.

Authors:  F Bordi; K D Carr; E Meller
Journal:  Brain Res       Date:  1989-06-12       Impact factor: 3.252

5.  Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats.

Authors:  H C Jackson; I Kitchen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.

Authors:  H Sershen; E Shearman; S Fallon; G Chakraborty; J Smiley; A Lajtha
Journal:  Brain Res Bull       Date:  2009-04-21       Impact factor: 4.077

7.  GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum.

Authors:  Andrea Balla; Megan E Nattini; Henry Sershen; Abel Lajtha; David S Dunlop; Daniel C Javitt
Journal:  Neuropharmacology       Date:  2009-02-06       Impact factor: 5.250

8.  Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release.

Authors:  A Guyon; D Skrzydelski; I De Giry; C Rovère; G Conductier; J M Trocello; V Daugé; P Kitabgi; W Rostène; J L Nahon; S Mélik Parsadaniantz
Journal:  Neuroscience       Date:  2009-05-27       Impact factor: 3.590

9.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

10.  The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  J Neurochem       Date:  1990-11       Impact factor: 5.372

View more
  7 in total

1.  Clinical characterization of bvFTD due to FUS neuropathology.

Authors:  Suzee E Lee; William W Seeley; Pardis Poorzand; Rosa Rademakers; Anna Karydas; Christine M Stanley; Bruce L Miller; Katherine P Rankin
Journal:  Neurocase       Date:  2011-11-07       Impact factor: 0.881

2.  Adolescent forced swim stress increases social anxiety-like behaviors and alters kappa opioid receptor function in the basolateral amygdala of male rats.

Authors:  E I Varlinskaya; J M Johnson; K R Przybysz; T Deak; M R Diaz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-11-07       Impact factor: 5.067

3.  Importance of D1 and D2 receptors in the dorsal caudate-putamen for the locomotor activity and stereotyped behaviors of preweanling rats.

Authors:  S Charntikov; T Der-Ghazarian; M S Herbert; L R Horn; C B Widarma; A Gutierrez; F A Varela; S A McDougall
Journal:  Neuroscience       Date:  2011-04-02       Impact factor: 3.590

4.  Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats.

Authors:  Fausto A Varela; Taleen Der-Ghazarian; Ryan J Lee; Sergios Charntikov; Cynthia A Crawford; Sanders A McDougall
Journal:  J Psychopharmacol       Date:  2013-09-17       Impact factor: 4.153

5.  Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.

Authors:  Jason J Paris; Kate J Reilley; Jay P McLaughlin
Journal:  J Addict Res Ther       Date:  2011-12-24

6.  Pharmacological activation of kappa opioid receptors: aversive effects in adolescent and adult male rats.

Authors:  Rachel I Anderson; Melissa Morales; Linda P Spear; Elena I Varlinskaya
Journal:  Psychopharmacology (Berl)       Date:  2013-04-19       Impact factor: 4.530

7.  Effects of the Alpha-1 Antagonist Prazosin on KOR Agonist-Induced Reinstatement of Alcohol Seeking.

Authors:  Douglas Funk; Kathleen Coen; Sahar Tamadon; A D Lê
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.